Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.
Trending
- Real Madrid’s Thibaut Courtois to miss crucial UCL tie vs. Bayern
- How to claim the new car loan interest deduction on your 2025 taxes
- Google: AI tool helped prevent heat-trapping contrails
- Japan’s leader heads to D.C. bearing gifts of peace for a president at war
- EEOC and Planned Parenthood chapter settle DEI-related case : NPR
- ‘Outlander’ Final Season Premieres to Nearly 3 Million Viewers
- Siena vs. Duke (Mar 19, 2026) Live Score
- Virginia SWAM bill faces legal challenges over race and sex, experts say
Thursday, March 19
A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved
